Brazil
· Delayed Price · Currency is BRL Biomm Statistics
Total Valuation
Biomm has a market cap or net worth of BRL 1.26 billion. The enterprise value is 1.23 billion.
| Market Cap | 1.26B |
| Enterprise Value | 1.23B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Biomm has 126.84 million shares outstanding. The number of shares has increased by 31.56% in one year.
| Shares Outstanding | 126.84M |
| Shares Change (YoY) | +31.56% |
| Shares Change (QoQ) | +14.20% |
| Owned by Insiders (%) | 11.27% |
| Owned by Institutions (%) | 43.70% |
| Float | 44.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.22 |
| PB Ratio | 4.15 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -15.65 |
| EV / Sales | 9.91 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.38 |
Financial Position
The company has a current ratio of 3.97, with a Debt / Equity ratio of 43.69.
| Current Ratio | 3.97 |
| Quick Ratio | 3.06 |
| Debt / Equity | 43.69 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.23 |
| Interest Coverage | -6.35 |
Financial Efficiency
Return on equity (ROE) is -36.82% and return on invested capital (ROIC) is -13.35%.
| Return on Equity (ROE) | -36.82% |
| Return on Assets (ROA) | -11.32% |
| Return on Capital (ROIC) | -13.35% |
| Revenue Per Employee | 952,162 |
| Profits Per Employee | -602,677 |
| Employee Count | 130 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 2.67 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +85.93% in the last 52 weeks. The beta is 0.82, so Biomm's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | +85.93% |
| 50-Day Moving Average | 10.37 |
| 200-Day Moving Average | 10.37 |
| Relative Strength Index (RSI) | 55.81 |
| Average Volume (20 Days) | 141,980 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biomm had revenue of BRL 123.78 million and -78.35 million in losses. Loss per share was -0.77.
| Revenue | 123.78M |
| Gross Profit | 27.94M |
| Operating Income | -76.68M |
| Pretax Income | -78.57M |
| Net Income | -78.35M |
| EBITDA | -64.98M |
| EBIT | -76.68M |
| Loss Per Share | -0.77 |
Balance Sheet
The company has 170.07 million in cash and 133.10 million in debt, giving a net cash position of 36.97 million or 0.29 per share.
| Cash & Cash Equivalents | 170.07M |
| Total Debt | 133.10M |
| Net Cash | 36.97M |
| Net Cash Per Share | 0.29 |
| Equity (Book Value) | 304.66M |
| Book Value Per Share | 2.40 |
| Working Capital | 214.40M |
Cash Flow
In the last 12 months, operating cash flow was -96.22 million and capital expenditures -11.59 million, giving a free cash flow of -107.81 million.
| Operating Cash Flow | -96.22M |
| Capital Expenditures | -11.59M |
| Free Cash Flow | -107.81M |
| FCF Per Share | -0.85 |
Margins
Gross margin is 22.57%, with operating and profit margins of -61.95% and -63.30%.
| Gross Margin | 22.57% |
| Operating Margin | -61.95% |
| Pretax Margin | -63.47% |
| Profit Margin | -63.30% |
| EBITDA Margin | -52.49% |
| EBIT Margin | -61.95% |
| FCF Margin | -87.09% |
Dividends & Yields
Biomm does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -31.56% |
| Shareholder Yield | -31.56% |
| Earnings Yield | -7.73% |
| FCF Yield | -8.53% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |